- Home
- WLKP vs MRVI Comparison
WLKP vs MRVI Comparison
Compare WLKP & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLKP
- MRVI
- Stock Information
- Founded
- WLKP 2014
- MRVI 2020
- Country
- WLKP United States
- MRVI United States
- Employees
- WLKP N/A
- MRVI N/A
- Industry
- WLKP Major Chemicals
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- WLKP Industrials
- MRVI Health Care
- Exchange
- WLKP Nasdaq
- MRVI Nasdaq
- Market Cap
- WLKP 819.6M
- MRVI 676.6M
- IPO Year
- WLKP 2014
- MRVI 2020
- Fundamental
- Price
- WLKP $24.07
- MRVI $5.23
- Analyst Decision
- WLKP
- MRVI Buy
- Analyst Count
- WLKP 0
- MRVI 10
- Target Price
- WLKP N/A
- MRVI $10.28
- AVG Volume (30 Days)
- WLKP 38.9K
- MRVI 1.8M
- Earning Date
- WLKP 02-18-2025
- MRVI 02-25-2025
- Dividend Yield
- WLKP 7.81%
- MRVI N/A
- EPS Growth
- WLKP 8.66
- MRVI N/A
- EPS
- WLKP 1.75
- MRVI N/A
- Revenue
- WLKP $1,143,109,000.00
- MRVI $276,920,000.00
- Revenue This Year
- WLKP N/A
- MRVI N/A
- Revenue Next Year
- WLKP $5.56
- MRVI $1.52
- P/E Ratio
- WLKP $13.78
- MRVI N/A
- Revenue Growth
- WLKP N/A
- MRVI N/A
- 52 Week Low
- WLKP $21.19
- MRVI $4.28
- 52 Week High
- WLKP $24.34
- MRVI $11.56
- Technical
- Relative Strength Index (RSI)
- WLKP 66.81
- MRVI 48.29
- Support Level
- WLKP $22.84
- MRVI $4.38
- Resistance Level
- WLKP $23.99
- MRVI $6.21
- Average True Range (ATR)
- WLKP 0.33
- MRVI 0.41
- MACD
- WLKP 0.10
- MRVI -0.05
- Stochastic Oscillator
- WLKP 90.65
- MRVI 46.45
About WLKP Westlake Chemical Partners LP Common Units representing limited partner interests
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develop ethyelene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.